Patent Number: 8,318,709

Title: Combination of azelastine and mometasone for nasal administration

Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.

Inventors: Lulla; Amar (Mumbai, IN), Malhotra; Geena (Mumbai, IN)

Assignee: Cipla Limited

International Classification: A01N 45/00 (20060101)

Expiration Date: 2021-11-27 0:00:00